Produces that which facilitates needle-free emergency treatment for severe allergic reactions through a convenient and cost-effective delivery platform.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Biothea Pharmaceuticals develops innovative pharmaceutical solutions focused on revolutionizing the management of severe allergic reactions and anaphylaxis. The organization concentrates on creating needle-free and cost-effective alternatives to traditional emergency treatments to improve patient accessibility and convenience.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Biothea Pharmaceuticals Management Team
Biothea Pharmaceuticals Valuations & Financials
View real-time NPM data on Biothea Pharmaceuticals stock including daily Biothea Pharmaceuticals stock price estimates, valuation history, and historical share price information. Access Biothea Pharmaceuticals financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Biothea Pharmaceuticals pricing across six independent market signals. Looking for private company due diligence data sources on Biothea Pharmaceuticals? Get in touch to learn more.
Similar Companies
like Biothea Pharmaceuticals
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Carepoynt
Healthcare & Life Sciences
Connects users with healthcare services while incentivizing healthy activities through a unified engagement platform.
Token.io
FinTech
Enables payments which leverage bank-account connectivity for seamless, lower-cost transactions.
iDonate
Enterprise Software
Helps nonprofits manage online fundraising, donor engagement, and digital donation processing.
Mammoth Biosciences
Healthcare & Life Sciences
Developed a CRISPR-based platform for disease to enable the detection of any type of nucleic acid.
Community Broadcasters
Media & Entertainment
Operates radio stations and providing diverse programming to engage and inform local communities.
N26
FinTech
Mobile banking platform that offers a range of financial services designed to simplify banking.
Cyemptive
Cybersecurity
Provides preemptive cybersecurity solutions that detect and neutralize threats before infiltration, using military-grade protection layers.
FAQ
We have answers
Biothea Pharmaceuticals stock does not trade on public stock exchanges. Biothea Pharmaceuticals stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Biothea Pharmaceuticals stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Biothea Pharmaceuticals Stock does not trade on public stock exchanges. In order to sell Biothea Pharmaceuticals shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Biothea Pharmaceuticals does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Biothea Pharmaceuticals share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Biothea Pharmaceuticals stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Biothea Pharmaceuticals stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Biothea Pharmaceuticals stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Biothea Pharmaceuticals is a private company and has not had an IPO. There is currently no Biothea Pharmaceuticals IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Biothea Pharmaceuticals IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
